参考文献

1.Chen W，Thomas J，Sadatsafavi M，et al.Risk of cardiovascular comorbidity in patientswith chronic obstructive pulmonary disease：a systematic review and meta-analysis.Lancet Respir Med，2015，3(8)：631-639.

2.Lahousse L，Verhamme KM，Stricker BH，et al.Cardiac effects of current treatments of chronic obstructive pulmonary disease.Lancet Respir Med，2016，4(2)：149-164.

3.Franssen FM，Soriano JB，Roche N，et al.Lung Function Abnormalities in Smokers with Ischemic Heart Disease.Am JRespir Crit Care Med，2016，194(5)：568-576.

4.中华医学会心血管病学分会，中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2014.中华心血管病杂志，2014，42(2)：98-122.

5.周春霞，江山平.慢性阻塞性肺疾病合并心血管疾病的研究进展.中华结核和呼吸杂志，2015，3(1)：72-75.

6.Dickstein K，Cohen.Solal A，Filippatos G，et al.ESC guidelines for the diagnosis and treatmentof acute and chronic heart failure2008：the task foree for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC(HFA)and endorsed by the European Society of Intensive Care Medicine(ESICM).Eur Heart J，2008，29：2388-2442.

7.Hawkins NM，Petrie MC，Macdonald MR，et al.Heart failure and chronic obstructive pulmonary disease the quandary of beta—blockers and betaagonists.JAm Coll Cardiol，201l，57：2127-2138.